Assertio Holdings, Inc.
NASDAQ: ASRT0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mark L. Reisenauer
- Employees
- 58
- Headquarters
- Lake Forest, United States
- IPO year
- 1997
- Market cap
- $151.9M
- Website
- https://www.assertiotx.com
Loading ASRT…
Loading profile data…Frequently asked questions about ASRT
What does Assertio Holdings, Inc. (ASRT) do?
Assertio Holdings, Inc. is a specialized pharmaceutical company focused on developing and commercializing therapeutic solutions across key medical domains, including neurology, hospital care, and pain and inflammation management. Among its portfolio, Assertio offers INDOCIN, available as both an oral solution and a suppository. This medication a...
Where does ASRT trade?
Assertio Holdings, Inc. (ASRT) trades on the NASDAQ Capital Market.
What sector is ASRT in?
Assertio Holdings, Inc. (ASRT) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Assertio Holdings, Inc.?
Mark L. Reisenauer is the chief executive officer of Assertio Holdings, Inc. (ASRT).
Where is Assertio Holdings, Inc. headquartered?
Assertio Holdings, Inc. is headquartered in United States.
Does ASRT pay a dividend?
Assertio Holdings, Inc. (ASRT) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ASRT go public?
Assertio Holdings, Inc. (ASRT) completed its initial public offering in 1997.